STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
TCRR TCR2 THERAPEUTICS INCORPORATED StockScouter® Report
8
StockScouter® Score
TCR2 THERAPEUTICS INCORPORATED, a micro cap company in the healthcare sector, is expected to outperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is well above average. Positive
- An executive, director or major shareholder purchased a large number of shares recently. Postive/Neutral
- Moving average analysis for TCRR suggests upward price movement over the medium term. Positive
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
F
A
N/A
A